Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.

@article{Hogg2006EfficacyOO,
  title={Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.},
  author={Ronald J. Hogg and Lisa Fitzgibbons and Carolyn Peluso Atkins and Nancy Nardelli and Ralph Curtis Bay},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2006},
  volume={1 6},
  pages={
          1167-72
        }
}
Previous studies that have evaluated fish oil preparations in patients with IgA nephropathy (IgAN) have produced a wide range of conclusions. Proposed explanations for these discordant results have not provided a unifying hypothesis. Results from two clinical trials were analyzed to examine whether there is a dosage-dependent effect of Omacor, a purified preparation of omega-3 fatty acids, in patients with IgAN. Whether changes in the level of proteinuria and plasma phospholipid fatty acid… CONTINUE READING
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Kincaid-Smith P: Treatment of IgA nephropathy with eicosapentaenoic acid (EPA): A two-year prospective trial

  • WM Bennett, RB Walker
  • Clin Nephrol 31:
  • 1989
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…